GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hualan Biological Vaccine Inc (SZSE:301207) » Definitions » 3-Year EBITDA Growth Rate

Hualan Biological Vaccine (SZSE:301207) 3-Year EBITDA Growth Rate : -2.70% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Hualan Biological Vaccine 3-Year EBITDA Growth Rate?

Hualan Biological Vaccine's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.07.

During the past 12 months, Hualan Biological Vaccine's average EBITDA Per Share Growth Rate was 23.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -2.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 16.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Hualan Biological Vaccine was 27.30% per year. The lowest was -2.70% per year. And the median was 6.80% per year.


Competitive Comparison of Hualan Biological Vaccine's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Hualan Biological Vaccine's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hualan Biological Vaccine's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hualan Biological Vaccine's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Hualan Biological Vaccine's 3-Year EBITDA Growth Rate falls into.



Hualan Biological Vaccine 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Hualan Biological Vaccine  (SZSE:301207) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Hualan Biological Vaccine 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Hualan Biological Vaccine's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Hualan Biological Vaccine (SZSE:301207) Business Description

Traded in Other Exchanges
N/A
Address
No. 1, No. 1, Hualan Avenue, Henan Province, Xinxiang, CHN, 453003
Website
Hualan Biological Vaccine Inc is engaged in Research, development, production and sales of human vaccines.

Hualan Biological Vaccine (SZSE:301207) Headlines

No Headlines